Eli Lilly Cardiometabolic Manufacturing Capex Announcements by Site (Cumulative)
Bar chart: Eli Lilly Cardiometabolic Manufacturing Capex Announcements by Site (Cumulative) for Eli Lilly. 2020-2025, values in USD billions. In 2025: Lebanon IN / LEAP (mega-site, parenteral + API) 13.5, Concord NC + RTP NC 3, Pleasant Prairie WI 4, Limerick IE + Alzey DE 4.5.
Eli Lilly Tirzepatide Quarterly Revenue: Mounjaro (T2D) vs Zepbound (Obesity)
Bar chart: Eli Lilly Tirzepatide Quarterly Revenue: Mounjaro (T2D) vs Zepbound (Obesity) for Eli Lilly. Q2 2022-Q1 2026, values in USD millions. In Q1 2026: Mounjaro (T2D) 8,700, Zepbound (Obesity) 4,100.
Revenue by Product/Service
Bar chart: Revenue by Product/Service for Eli Lilly. 2021-Q2-2026-Q1, values in B. In 2026-Q1: Cardiometabolic Health 15.76, Oncology 2.268, Immunology 1.203, Neuroscience 0.382, Other Product, Total 0, Diabetes 0, and 9 more.
Revenue by Geography
Bar chart: Revenue by Geography for Eli Lilly. 2021-Q2-2026-Q1, values in B. In 2026-Q1: United States 12.119, Non-US 10.451, Europe 3.646, China 0.693, Japan 0.571, Other Foreign Countries 0.
Employee Count
Line chart: Employee Count for Eli Lilly. 1993-2025. Employees: 32,700 in 1993 to 50,000 in 2025.